Spiro Rombotis
2022
In 2022, Spiro Rombotis earned a total compensation of $763.6K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Bonus | $169,406 |
|---|---|
| Salary | $546,470 |
| Other | $47,675 |
| Total | $763,551 |
Rombotis received $546.5K in salary, accounting for 72% of the total pay in 2022.
Rombotis also received $169.4K in bonus and $47.7K in other compensation.
Rankings
In 2022, Spiro Rombotis' compensation ranked 3,597th out of 5,717 executives tracked by ExecPay. In other words, Rombotis earned more than 37.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,597 out of 5,717 | 37th |
Division Manufacturing | 2,041 out of 3,111 | 34th |
Major group Chemicals And Allied Products | 976 out of 1,410 | 31st |
Industry group Drugs | 913 out of 1,311 | 30th |
Industry Pharmaceutical Preparations | 664 out of 957 | 31st |
Source: SEC filing on April 28, 2023.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2022.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020